pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Phase 2
    CBP-1019
    Breast Cancer Coherent Biopharma
  • Phase 2
    CBP-501
    Pancreatic Cancer CanBas Co Ltd
  • Preclinical
    CBP/p300 Inhibitors
    Central Nervous System (CNS) Cancer Sumitomo Pharma Co Ltd
  • Phase 2
← prev
page 14 of 62
next →
Pain89
Neurology1
CBX-12
Colorectal Cancer
Cybrexa Inc
  • Preclinical
    CC-2401
    Solid Tumor CytoCan Corp
  • Preclinical
    CC-2402
    Solid Tumor CytoCan Corp
  • Phase 1
    CCAR-066
    Diffuse Large B-Cell Lymphoma Janssen Biotech Inc
  • Phase 1
    CD38-SADA
    B-Cell Non-Hodgkin Lymphoma Y-mAbs Therapeutics Inc
  • Preclinical
    CDKN2A Program
    Pancreatic Cancer$IDYA IDEAYA Biosciences, Inc.
  • Phase 1
    CDR-404
    Head And Neck Squamous Cell Carcinoma (HNSC) CDR-Life Inc
  • Preclinical
    CDX Program
    Refractory Acute Myeloid Leukemia HemoGenyx Pharmaceuticals Plc
  • Phase 2
    CEP-11981
    Pancreatic Cancer$TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
  • Phase 2
    CER-1236
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)$CERO CERO THERAPEUTICS HOLDINGS, INC.
  • Phase 2
    CFI-402411
    Anal Cancer Treadwell Therapeutics Inc
  • Preclinical
    CG-923308
    Breast Cancer$GYRE GYRE THERAPEUTICS, INC.
  • Preclinical
    CGT-1263
    Unspecified Cancer$COGT Cogent Biosciences, Inc.
  • Phase 1
    CHECKVacc
    Triple-Negative Breast Cancer (TNBC) Imugene Ltd
  • Phase 1
    CHM-0201
    Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Chimeric Therapeutics Ltd
  • Phase 2
    CHM-2101
    Colon Cancer Chimeric Therapeutics Ltd
  • Phase 2
    CHOH-01
    B-Cell Non-Hodgkin Lymphoma CHO Pharma Inc
  • Preclinical
    CHT-103
    Hematological Tumor Nanjing Miracle Biotechnology Co Ltd
  • Preclinical
    CHT-104
    Hematological Tumor Nanjing Miracle Biotechnology Co Ltd
  • Preclinical
    CHT-105
    Autoimmune Disorders Nanjing Miracle Biotechnology Co Ltd
  • Preclinical
    CIB-201
    Renal Cell Carcinoma Cellinfinity Bio Inc
  • Phase 1
    CID-078
    Human Epidermal Growth Factor Receptor 2 Negative Breast… Circle Pharma Inc
  • Phase 1
    CK-0801
    Myelodysplastic Syndrome (Preleukemia) Cellenkos Inc
  • Preclinical
    CL-04177
    Hematological Tumor Cleara Biotech BV
  • Preclinical
    CL-04183
    Metastatic Colorectal Cancer Cleara Biotech BV
  • Phase 1
    CLBR-001
    B-Cell Chronic Lymphocytic Leukemia California Institute for Biomedical Research
  • Phase 1
    CLD-101
    Anaplastic Astrocytoma$CLDI Calidi Biotherapeutics, Inc.